GALLAGHER, Michela,HABERMAN, Rebecca,KOH, Ming Teng
申请号：
HK18108219
公开号：
HK1248543A1
申请日:
2018.06.26
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
This invention relates to treating age-relative cognitive impairment. This invention in particular relates to the use of inhibitors of synaptic vesicle protein 2A (SV2A), such as levetiracetam, seletracetam, and brivaracetam, in improving cognitive function in subjects that exhibit age-related cognitive impairment or are at risk thereof, including, without limitation, subjects having or at risk for Mild Cognitive Impairment (MCI), Age-related Cognitive Decline (ARCD) or Age-Associated Memory Impairment (AAMI).
